No Data
No Data
Is It Too Late To Consider Buying RxSight, Inc. (NASDAQ:RXST)?
RxSight, Inc. (NASDAQ:RXST), might not be a large cap stock, but it received a lot of attention from a substantial price increase on the NASDAQGM over the last few months. While good news for sh
RxSight Insider Sold Shares Worth $906,288, According to a Recent SEC Filing
Julie Andrews, Director, on June 14, 2024, sold 15,625 shares in RxSight (RXST) for $906,288. Following the Form 4 filing with the SEC, Andrews has control over a total of 30,287 shares of the company
Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST)
RxSight(RXST.US) Director Sells US$906.29K in Common Stock
$RxSight(RXST.US)$ Director Andrews Julie sold 15,625 shares of common stock on Jun 14, 2024 at an average price of $58.0024 for a total value of $906.29K.Source: Announcement What is statement of cha
Form 144 | RxSight(RXST.US) Director Proposes to Sell 922.34K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 14, $RxSight(RXST.US)$ Director Julie Andrews intends to sell 15,625 shares of its common stock on Jun 14, with a total market value of approximately $922.34K. Source: A
RxSight, Inc. To Participate in the Truist Securities Medtech Conference